Acute haemolysis and appearance of PNH-like clones in patients with vitamin B12 deficiency and iron deficiency after iron dextran administration

Size: px
Start display at page:

Download "Acute haemolysis and appearance of PNH-like clones in patients with vitamin B12 deficiency and iron deficiency after iron dextran administration"

Transcription

1 Acute haemolysis and appearance of PNH-like clones in patients with vitamin B12 deficiency and iron deficiency after iron dextran administration Chun-Liang Lin 1, Chin-Chan Lin 1,Wen-Jyi Lo 2,Yu-Chien Chang 2,Chang-Fang Chiu 1 1.Division of Haematology and Oncology, Department of Internal Medicine, China Medical University Hospital, Taichung, Taiwan 2.Stem Cell Research Laboratory and Tissue Bank, CMUH, Taiwan

2 Present illness A 29-year-old woman Presented with to dyspena for two weeks She had received ileum resection at the age of seven -suppurative appendicitis

3 Course1 Hb MCV WBC PLT ferritin vitamin B12 (mecobolamin) 7.0 g/dl 68.6 fl 5200 ul 313,000 ul 1.8 ng/ml <50 pg/ml after IV iron supplementation of two weeks dyspnea worsened

4 Course1 Re-check of data Hb 5.8 g/dl MCV 91.7 fl WBC 2580 ul PLT 149,000 ul reticulocytes 0.66 % total bilirubin 1.63 mg/dl direct bilirubin 0.29mg/dl LDH 2868 U/L haptoglobin <5 mg/dl Direct and indirect Coomb s tests (-)

5 Peripheral blood smear macrocytic anemia with anisocytosis, poikilocytosis.

6 Bone marrow examination hypercellularity, (cellularity: 90-95%) with megaloblastoid change. The M/E ratio is markedly increased due to proliferation of mature and immature myeloid cells with dispersed erythroid. cytogenetic studies revealed 46XX in the analysis of 25 cells.

7 Differential diagnosis Coombs negative hemolytic anemia Drugs Toxins Microangiopathic hemolytic anemia infections Membrane disorders: Paroxysmal nocturnal hemoglobinuria Liver disease

8 Peripheral blood sampling Flow cytometric evaluation population of FLAER-deficient granulocytes 7.6% population of CD59-deficient 9.6% RBC Blood, Charles Parker,

9 PNH-like clones (Before vit B12 treatment) Before Control Before RBC WBC

10 Course2 One week - mecobolamin was administrated reticulocytes 13.79% Two weeks - mecobolamin supplementation haemoglobin 7.7 g/dl MCV 68.4 fl Four weeks - mecobolamin supplementation Flow cytometric evaluation population of FLAER-deficient granulocytes 0% population of CD59-deficient RBC 2.2%

11 PNH-like clones (After vit B12 treatment) After After RBC WBC WBC

12 Course3 Intravenous iron dextran was re-challenged- no haemolysis 3 months after vitamin B12 and iron supplementation haemoglobin 11 g/dl the patient was in health status.

13 Discussion

14 Vitamin B12 deficiency and RBC destruction Intramedullary destruction is well understand. But intravascular haemolysis in advance anemia is rare.

15 Mechanism of RBC destruction 1. Abnormalities of erythrocyte membrane proteins, ex: spectrin. 2. Severe hyperhomocysteinemia caused by vitamin B12 deficiency and MTHFR(methylenetetrahydrofolate reductase) gene mutations and vitamin B12 deficiency possibly related to peripheral blood hemolysis. Journal of hematology & oncology, Acharya U.2008;1:26 Journal of clinical investigation 1978, Ballas SK,61,

16 7% PNH-like clones in our vitamin B12 deficiency of patient PIG-A mutant blood cells are in the blood and bone marrow of healthy person %. Aplastic anemia and myelodysplastic syndromes also harbor small populations less than 1%. Haematol,Jeffrey J, Nephrology,dialysis,transplantation,Buus NH 2007,22,661-2

17 PNH and acute hemolysis Precipitating factor: infection surgery transfusions iron supplementation vaccination menstruation Wintrobe s clinical hematology, 12 edition, Vygovskaia.1982;27:39-42

18 PNH and acute hemolysis The haemolysis after iron supplement probably - outpouring of a cohort of young erythrocytes, a larger proportion of which is more complement sensitive than those in the older antecedent population Blood 2005, Hu R. 105,

19 Haemolysis after iron dextran treatment One case report by Niel Hernri (Buus et al, 2007) - a patient developed severe intravascular haemolysis and acute renal failure following intravenous administration of iron dextran. As we known, there was no report about acute haemolylsis in patients with vitamin B12 deficiency after iron dextran administration. Nephrology,dialysis, transplantation, Buus NH 2007,22,661-2

20 conclusion We found a case presented with advanced vitamin B12 deficiency and iron deficiency anemia complicated with acute haemolysis after iron administration and appearance of PNH-like clones, both of which subsided after vitamin B12 administration. Our case Typical PNH

21 The linking of vitamin B12 deficiency and the The linking of vitamin B12 deficiency and the formation of PNH-like clones is intriguing.

22 Thank you for your listening!

Diagnostic Approach to Patients with Anemia

Diagnostic Approach to Patients with Anemia J KMA Special Issue Diagnostic Approach to Patients with Anemia Seonyang Park, MD Department of Internal Medicine, Seoul National University College of Medicine E mail : seonpark@snu.ac.kr J Korean Med

More information

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation

CASE 106. Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation CASE 106 Pancytopenia in the setting of marrow hypoplasia, a PNH clone, and a DNMT3A mutation Gabriel C. Caponetti, MD University of Pennsylvania, US Clinical history 69, F peripheral neuropathy, refractory

More information

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009

Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009 HAEMOLYTIC ANAEMIA Dairion Gatot, Soegiarto Ganie, Savita Handayani. Divisi Hematologi & Onkologi Medik Departemen Ilmu Penyakit Dalam FK-USU/RS H.Adam Malik Medan 2009 WHEN BY THEN Hb 9 g% transfusion

More information

Hematology: Challenging Cases with Your Participation COPYRIGHT

Hematology: Challenging Cases with Your Participation COPYRIGHT Hematology: Challenging Cases with Your Participation Reed E. Drews, MD Beth Israel Deaconess Medical Center Harvard Medical School Boston, MA Question 1 Question 1 64-year-old man is evaluated during

More information

Living with PNH 7/3/2013. Paroxysmal Nocturnal Hemoglobinuria (PNH): A Chronic, Systemic, and Life- Threatening Disease

Living with PNH 7/3/2013. Paroxysmal Nocturnal Hemoglobinuria (PNH): A Chronic, Systemic, and Life- Threatening Disease Living with PNH Laurence A. Boxer, MD University of Michigan Case Study 15 year old awakened in the morning with chest pain and a sore throat. She experienced chest pain all day accompanied with coughing

More information

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi

Anemia (3).ms4.25.Oct.15 Hemolytic Anemia. Abdallah Abbadi Anemia (3).ms4.25.Oct.15 Hemolytic Anemia Abdallah Abbadi Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k, retics 12%, LDH

More information

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore

HAEMATOLOGICAL EVALUATION OF ANEMIA. Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore HAEMATOLOGICAL EVALUATION OF ANEMIA Sitalakshmi S Professor and Head Department of Clinical Pathology St John s medical College, Bangalore Learning Objectives Laboratory tests for the evaluation of anemia

More information

Pathophysiology 7/18/2012 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA

Pathophysiology 7/18/2012 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA PAROXYSMAL NOCTURNAL HEMOGLOBINURIA OUTLINE OF DISCUSSION WHAT IS IT WHO GETS IT NATURAL HISTORY TYPES RISKS COURSE TREATMENTS SYMPTOMS PREGNANCY Pathophysiology Acquired hematopoietic stem cell disorder

More information

MORPHOLOGY IN ACTION. Description MINI-CASE ONE OBJECTIVES. Differential Diagnosis. Laboratory Results

MORPHOLOGY IN ACTION. Description MINI-CASE ONE OBJECTIVES. Differential Diagnosis. Laboratory Results MORPHOLOGY IN ACTION Mini-case studies using morphology Bernadette Rodak, MS, MT, SH(ASCP) Professor emeritus Indiana University brodak@iupui.edu Description Mini-case studies will be used to integrate

More information

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh

Anemia (3).ms Hemolytic Anemia. Abdallah Abbadi Feras Fararjeh Anemia (3).ms4.26.2.18 Hemolytic Anemia Abdallah Abbadi Feras Fararjeh Case 3 24 yr old female presented with anemia syndrome and jaundice. She was found to have splenomegaly. Hb 8, wbc 12k, Plt 212k,

More information

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals

I. Definitions. V. Evaluation A. History B. Physical Exam C. Laboratory evaluation D. Bone marrow examination E. Specialty referrals I. Definitions II. III. Red blood cell life cycle Iron metabolism IV. Causes of anemia A. Kinetic approach 1. decreased production 2. increased destruction 3. blood loss B. Morphologic approach 1. normocytic

More information

10/27/2017 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DANIEL LANDAU, MD PNH TYPICAL CASE

10/27/2017 PAROXYSMAL NOCTURNAL HEMOGLOBINURIA DANIEL LANDAU, MD PNH TYPICAL CASE PAROXYSMAL NOCTURNAL HEMOGLOBINURIA Daniel Landau, MD Orlando Health: UF Health Cancer Center Hematologist/ Oncologist Orlando Health University of Florida Cancer Center Section Chief of Hematology/Oncology

More information

Clinical Roundtable Monograph

Clinical Roundtable Monograph Clinical Roundtable Monograph Clinical Advances in Hematology & Oncology April 2018 Clinical Consequences of Paroxysmal Nocturnal Hemoglobinuria and Aplastic Anemia: A Multidisciplinary Discussion PLUS

More information

New phase 2 Clinical Trial Enrolling Now

New phase 2 Clinical Trial Enrolling Now New phase 2 Clinical Trial Enrolling Now Warm Autoimmune Hemolytic Anemia (waiha) and Cold Agglutinin Disease (CAD) Designed for patients Age 18 or older With a primary diagnosis of waiha who had a recurrence,

More information

SESSION 1 Reactive cytopenia and dysplasia

SESSION 1 Reactive cytopenia and dysplasia SESSION 1 Reactive cytopenia and dysplasia Falko Fend, Tübingen & Alexandar Tzankov, Basel 1 Disclosure of speaker s interests (Potential) conflict of interest none Potentially relevant company relationships

More information

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC

Evaluation of Anemia. Md. Shafiqul Bari Associate professor (Medicine) SOMC Evaluation of Anemia Md. Shafiqul Bari Associate professor (Medicine) SOMC Definition Anemia is operationally defined as a reduction in one or more of the major RBC measurements Hemoglobin concentration

More information

New phase 2 Clinical Trial Enrolling Now

New phase 2 Clinical Trial Enrolling Now New phase 2 Clinical Trial Enrolling Now Warm Autoimmune Hemolytic Anemia (waiha) and Cold Agglutinin Disease (CAD) Designed for patients Age 18 or older With a primary diagnosis of waiha who had a recurrence,

More information

The use of the complement inhibitor eculizumab (Soliris R ) for treating Korean patients with paroxysmal nocturnal hemoglobinuria

The use of the complement inhibitor eculizumab (Soliris R ) for treating Korean patients with paroxysmal nocturnal hemoglobinuria VOLUME 45 ㆍ NUMBER 4 ㆍ December 2010 THE KOREAN JOURNAL OF HEMATOLOGY ORIGINAL ARTICLE The use of the complement inhibitor eculizumab (Soliris R ) for treating Korean patients with paroxysmal nocturnal

More information

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017

Anemia. A case-based approach. David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Anemia A case-based approach David B. Sykes, MD, PhD Hematology, MGH Cancer Center June 8, 2017 Recognizing trends Learning Objectives MCV, RDW, Ferritin, LDH, Reticulocytes Managing complex patients 1.

More information

Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria Barry Skikne MD, FACP, FCP(SA) Professor of Hematology Division of Hematologic Malignancies and Cellular Therapeutics Cardinal Clinical Manifestations PNH Clonal disease

More information

HEMATOPOIESIS. HEMATOLOGY Introduction. Study of blood & its components Window of rest of body. Introduction

HEMATOPOIESIS. HEMATOLOGY Introduction. Study of blood & its components Window of rest of body. Introduction HEMATOLOGY/ HEMATOPOIESIS Introduction HEMATOLOGY Introduction Study of blood & its components Window of rest of body 1 BLOOD Raison d etre Delivery of nutrients Oxygen Food Vitamins Removal of wastes

More information

PNH. PNH A study case 5/9/2012. PNH Current Thinking on the Disease, Diagnosis, and Treatment. Where have we been, where are we going?

PNH. PNH A study case 5/9/2012. PNH Current Thinking on the Disease, Diagnosis, and Treatment. Where have we been, where are we going? PNH Current Thinking on the Disease, Diagnosis, and Treatment Where have we been, where are we going? Carlos M. de Castro, MD Duke University Medical Center PNH Case What is PNH? What causes PNH? Relationship

More information

Year 2003 Paper two: Questions supplied by Tricia

Year 2003 Paper two: Questions supplied by Tricia QUESTION 65 A 36-year-old man presents in a post-ictal state after an observed generalised seizure. Full blood investigation shows: haemoglobin 0 g/l [128-175] mean corpuscular volume (MCV) 106 fl [80-7]

More information

New Phase III Clinical Trial Enrolling Now

New Phase III Clinical Trial Enrolling Now New Phase III Clinical Trial Enrolling Now Paroxysmal Nocturnal Hemoglobinuria (PNH) Designed for Patients 1. At least 18 years of age 2. With a primary diagnosis of PNH confirmed by high-sensitivity flow

More information

Drug induced hemolysis: transfusion management Interactive case study

Drug induced hemolysis: transfusion management Interactive case study Drug induced hemolysis: transfusion management Interactive case study Kurt Anseeuw, MD Department of Emergency Medicine ZNA Stuivenberg Antwerp, Belgium Case 1 Male patient, 50 y History Nil Chief Complaint

More information

4/17/2018. Paroxysmal Nocturnal Hemoglobinuria: Paroxysmal Nocturnal Hemoglobinuria. Epidemiology. PNH Stem Cell.

4/17/2018. Paroxysmal Nocturnal Hemoglobinuria: Paroxysmal Nocturnal Hemoglobinuria. Epidemiology. PNH Stem Cell. Paroxysmal Nocturnal Hemoglobinuria: Understanding the Diagnosis, Complications and Treatment Options Iberia Romina Sosa, MD, PhD Assistant Professor of Medicine Baylor College of Medicine April 21, 2018

More information

PNH Glossary of Terms

PNH Glossary of Terms AA Absolute neutrophil count Alendronate Allergen ALT Anemia Antibodies Anticoagulant Anticoagulation Antigen Antithymocyte globulin (ATG) Aplastic Aplastic anemia Band Bilirubin Blast cells Bone marrow

More information

Case Report A Puzzle of Hemolytic Anemia, Iron and Vitamin B12 Deficiencies in a 52-Year-Old Male

Case Report A Puzzle of Hemolytic Anemia, Iron and Vitamin B12 Deficiencies in a 52-Year-Old Male Hindawi Publishing Corporation Case Reports in Hematology Volume 2013, Article ID 708489, 5 pages http://dx.doi.org/10.1155/2013/708489 Case Report A Puzzle of Hemolytic Anemia, Iron and Vitamin B12 Deficiencies

More information

Hematology Unit Lab 1 Review Material

Hematology Unit Lab 1 Review Material Hematology Unit Lab 1 Review Material - 2018 Objectives Laboratory instructors: 1. Assist students during lab session Students: 1. Review the introductory material 2. Study the case histories provided

More information

Approach to a pale child

Approach to a pale child Approach to a pale child Dr. Dafalla Ahmed Babiker Jazan university objectives Definition of anemia Classification and causes Important points in history and physical examination Investigations. Definition

More information

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do?

MDS 101. What is bone marrow? Myelodysplastic Syndrome: Let s build a definition. Dysplastic? Syndrome? 5/22/2014. What does bone marrow do? 101 May 17, 2014 Myelodysplastic Syndrome: Let s build a definition Myelo bone marrow Gail J. Roboz, M.D. Director, Leukemia Program Associate Professor of Medicine What is bone marrow? What does bone

More information

Faculty of Medicine Dr. Tariq Aladily

Faculty of Medicine Dr. Tariq Aladily Iron deficiency anemia The most common anemia worldwide Only 10% of ingested iron is absorbed Most dietary iron occurs in meat products Absorbed in duodenum Hepcidin By inhibiting ferroportin, hepcidin

More information

Abdominal pain in combination with an unexplained hemolytic anemia are crucial signs to test for paroxysmal nocturnal hemoglobinuria: A case report

Abdominal pain in combination with an unexplained hemolytic anemia are crucial signs to test for paroxysmal nocturnal hemoglobinuria: A case report Received: 22 January 2018 Revised: 25 April 2018 DOI: 10.1002/ccr3.1771 Accepted: 9 June 2018 CASE REPORT Abdominal pain in combination with an unexplained hemolytic anemia are crucial signs to test for

More information

UNUSUAL PRESENTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS

UNUSUAL PRESENTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS UNUSUAL PRESENTATIONS OF SYSTEMIC LUPUS ERYTHEMATOSUS Presenter- Dr. Meghana B S Prof Dr. NAGARAJA B S Prof Dr. NIRMALA A C Dr. SIVARANJANI H Dr. B C PRAKASH Dr. MUMTAZ ALI KHAN A 60 year old lady, k/c/o

More information

Updates in the Management of Anemia in Cancer. Taylor M. Ortiz, MD May 19, 2017

Updates in the Management of Anemia in Cancer. Taylor M. Ortiz, MD May 19, 2017 Updates in the Management of Anemia in Cancer Taylor M. Ortiz, MD May 19, 2017 Objectives Recall common causes of anemia in patients with cancer Understand risks/benefits of blood transfusion in patients

More information

Passenger Lymphocyte Syndrome (case presentation) Dr. Namal Bandara Kings College Hospital

Passenger Lymphocyte Syndrome (case presentation) Dr. Namal Bandara Kings College Hospital Passenger Lymphocyte Syndrome (case presentation) Dr. Namal Bandara Kings College Hospital Case history 24year Female Known Patient with Wilsons Disease DBD donor Liver Transplantation done on 15/08/2016

More information

Participants Identification No. % Evaluation. Spherocyte Educational Erythrocyte, normal Educational

Participants Identification No. % Evaluation. Spherocyte Educational Erythrocyte, normal Educational Cell Identification VPBS-14 Participants Identification No. % Evaluation Spherocyte 885 97.3 Educational Erythrocyte, normal 19 2.1 Educational The arrows point to spherocytes, correctly identified by

More information

What is PNH? PNH: What it is Not 9/11/2015. What is Paroxysmal Nocturnal Hemoglobinuria?

What is PNH? PNH: What it is Not 9/11/2015. What is Paroxysmal Nocturnal Hemoglobinuria? 9/11/15 PNH: Current Thinking on the Disease, Diagnosis, and Treatment Joseph H. Antin, MD Professor of Medicine Harvard Medical School Jock and Bunny Adams Chair in Hematology Dana-Farber/Brigham and

More information

HEMATOPATHOLOGY SUMMARY REPORT RL;MMR;

HEMATOPATHOLOGY SUMMARY REPORT RL;MMR; HEMATOPATHOLOGY SUMMARY REPORT RL;MMR; Page 1 of 1 05/15/20XX HP000000-20XX 05/21/20XX (212) 123-457 (51) 32-3455 (51) 123-457 Age: 78 DOB: 0/05/19XX SS#: 45-45-45 Clinical Information: 78 y/o female with

More information

2013 AAIM Pathology Workshop

2013 AAIM Pathology Workshop 2013 AAIM Pathology Workshop John Schmieg, M.D., Ph.D. None Disclosures 1 Pathology Workshop Objectives Define the general philosophy of reviewing pathology reports Review the various components of Bone

More information

General Characterisctics

General Characterisctics Anemia General Characterisctics Definition: anemia is a decrease in red blood cells. Happens due to underproduction, increased destruction or loss of red cells. Diagnosis of anemia: Hgb < 135 (men) Hgb

More information

Key terms: aplastic anemia; complement inhibitors; paroxysmal nocturnal hemoglobinuria

Key terms: aplastic anemia; complement inhibitors; paroxysmal nocturnal hemoglobinuria Cytometry Part B (Clinical Cytometry) 94B:16 22 (2018) Original Article ICCS/ESCCA Consensus Guidelines to detect GPI-deficient cells in Paroxysmal Nocturnal Hemoglobinuria (PNH) and related Disorders

More information

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY

THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY THE UNIVERSITY OF JORDAN FACULTY OF MEDICINE DEPARTMENT OF PATHOLOGY INTRODUCTION TO ANEMIA Third year medical students First semester 2018/2019 Dr. RBC DISORDERS Lecturer: Dr. Tariq Al-Adaily Email: TNALADILY@ju.edu.jo

More information

Case # 1. RBC Loss. CASE #1 (Continued) Blood Loss Is the Most Common Cause of Anemia. AGA Definition of Occult Blood Loss

Case # 1. RBC Loss. CASE #1 (Continued) Blood Loss Is the Most Common Cause of Anemia. AGA Definition of Occult Blood Loss Case # 1 A 42-yo woman with heavy menses presents with rectal bleeding. Except for pallor, exam is normal. HCT = 17.1% (normal, 36-48) HGB = 5.3 g/dl (normal, 12.0-16.0) MCV = 76 fl (normal, 82-98) RBC

More information

Early View Article: Online published version of an accepted article before publication in the final form.

Early View Article: Online published version of an accepted article before publication in the final form. : Online published version of an accepted article before publication in the final form. Journal Name: Journal of Case Reports and Images in Medicine Type of Article: Case Report Title: Paroxysmal cold

More information

INTERELATIONSHIP BETWEEN IDA AND VITAMIN D DEFICIENCY IS NOW ESTABLISHED

INTERELATIONSHIP BETWEEN IDA AND VITAMIN D DEFICIENCY IS NOW ESTABLISHED INTERELATIONSHIP BETWEEN IDA AND VITAMIN D DEFICIENCY IS NOW ESTABLISHED Rationale for Combining Iron & Vit-D Vit D deficiency and Iron deficiency Anaemia the two most menacing disorders - are inter-related

More information

Acknowledgments. Michael Brown Petra Muus for case reports

Acknowledgments. Michael Brown Petra Muus for case reports Current treatment strategy for PNH Jeff Szer Professor/Director, Department of Clinical Haematology & BMT Service The Royal Melbourne Hospital Australia Acknowledgments Michael Brown Petra Muus for case

More information

Approach to Anemia PG CME

Approach to Anemia PG CME Approach to Anemia PG CME 2014 2017 Vikram Mathews Haematology Department Christian Medical College Vellore Definition of Anemia Beutler et al. Blood 2006. Definition of Anemia WHO definition of anemia

More information

HEMATOLOGY/ HEMATOPOIESIS

HEMATOLOGY/ HEMATOPOIESIS HEMATOLOGY/ HEMATOPOIESIS Introduction HEMATOLOGY Introduction! Study of blood & its components! Window of rest of body 1 BLOOD Raison d etre! Delivery of nutrients!oxygen!food!vitamins! Removal of wastes!carbon

More information

Hemolytic Anemia. Hemolytic Anemia Classification Intracorpuscular Defects. Hemolytic Anemia Classification

Hemolytic Anemia. Hemolytic Anemia Classification Intracorpuscular Defects. Hemolytic Anemia Classification Hemolytic Anemia Fletcher A. Miller, Jr, MD Mayo Clinic Rochester Valve Related Hemolysis Case Based presentation Shortened survival of red blood cells due to premature destruction Typical RBC lifespan

More information

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD

Hematology 101. Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematology 101 Blanche P Alter, MD, MPH, FAAP Clinical Genetics Branch Division of Cancer Epidemiology and Genetics Bethesda, MD Hematocrits Plasma White cells Red cells Normal, Hemorrhage, IDA, Leukemia,

More information

PNH PNH PNH 3/22/2016 PNH. Paroxysmal Nocturnal Hemoglobinuria (PNH): Current Thinking on the Disease PATHOGENESIS OF PNH

PNH PNH PNH 3/22/2016 PNH. Paroxysmal Nocturnal Hemoglobinuria (PNH): Current Thinking on the Disease PATHOGENESIS OF PNH 3//1 PATHGENESIS F PIG-A gene Bone Marrow Failure Disease Scientific Symposium Rockville, March 17-1, 1 1 71 9 3 Paroxysmal Nocturnal Hemoglobinuria (): Current Thinking on the Disease 119 5 15 PRTEIN

More information

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc.

Examination Tests from Pathological Physiology. Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc. Examination Tests from Pathological Physiology Pavel Maruna et al. Reviewed by: Prof. MUDr. Emanuel Nečas, DrSc. Prof. MUDr. Jaroslav Veselý, CSc. Authors: Prof. MUDr. Pavel Maruna, CSc. Doc. MUDr. Martin

More information

Prof. Mahmoud Rushdi Faculty of Veterinary Medicine Assiut University Egypt. RBCs counts. Anaemia.

Prof. Mahmoud Rushdi Faculty of Veterinary Medicine Assiut University Egypt.   RBCs counts. Anaemia. By Prof. Mahmoud Rushdi Faculty of Veterinary Medicine Assiut University Egypt ١ RBCs counts Normal Anaemia Polycythaemia Morphological Etiological Relative Absolute Size Stain Shape Inclusion Hemorrhagic

More information

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired

Interpreting the CBC. Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired Interpreting the CBC Robert Miller PA Assistant Professor of Clinical Pediatrics and Family Medicine USC Keck School of Medicine Retired The CBC 3 Cell Lines RBCs WBCs Platelets Assess general health Make

More information

SOLIRIS (eculizumab) Slide # 1. How do we treat PNH?

SOLIRIS (eculizumab) Slide # 1. How do we treat PNH? Treating PNH How do we treat PNH? Hemolytic anemia Iron, folic acid Transfusion Steroids Eculizumab Thrombosis Coumadin prophylaxis Acute treatment with lytic agents (clot busters) Anticoagulation therapy

More information

Aplastic anamia & Sideroblastic anemia

Aplastic anamia & Sideroblastic anemia Hematology Lecture 7 كلية التقنيات الصحية والطبية قسم التحليالت المرضية Aplastic anamia & Sideroblastic anemia اإلعداد: ظفر جبار دهاق فؤاد APLASTIC ANEMIA What is Aplastic anemia? Aplastic anemia is a

More information

International Journal of Case Reports in Medicine

International Journal of Case Reports in Medicine International Journal of Case Reports in Medicine Vol. 2014 (2014), Article ID 504318, 21 minipages. DOI:10.5171/2014.504318 www.ibimapublishing.com Copyright 2014 Pinar Tosun Taşar, Sevnaz Sahin, Asu

More information

FBC CASES Vernon Louw Clinical Haematology 2010

FBC CASES Vernon Louw Clinical Haematology 2010 FBC CASES Vernon Louw Clinical Haematology 2010 FOR EACH OF THE FOLLOWING PATIENTS, SELECT THE MOST LIKELY FINDING FROM THE ANALYSIS OF THE PERIPHERAL BLOOD. A patient with infectious mononucleosis. A

More information

9/19/2017. PNH Understanding your diagnosis and treatment. Paroxysmal Nocturnal Hemoglobinuria (PNH) Paroxysmal Nocturnal Hemoglobinuria

9/19/2017. PNH Understanding your diagnosis and treatment. Paroxysmal Nocturnal Hemoglobinuria (PNH) Paroxysmal Nocturnal Hemoglobinuria August_20_2010US Patients Surviving (%) Paroxysmal Nocturnal Hemoglobinuria (PNH) PNH Understanding your diagnosis and treatment Hugo Castro-Malaspina, MD Memorial Sloan Kettering Cancer Center New York,

More information

Symptoms and Signs in Hematology (2)/ 2013

Symptoms and Signs in Hematology (2)/ 2013 Symptoms and Signs in Hematology (2)/ 2013 Abdallah Abbadi.MD.FRCP Professor of Medicine,Hematology & Oncology University of Jordan & JUH Email: abdalla.awidi@gmail.com Case one: A 24 yr old female complains

More information

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018

The function of the bone marrow. Living with Aplastic Anemia. A Case Study - I. Hypocellular bone marrow failure 5/14/2018 The function of the bone marrow Larry D. Cripe, MD Indiana University Simon Cancer Center Bone Marrow Stem Cells Mature into Blood Cells Mature Blood Cells and Health Type Function Term Red Cells Carry

More information

Dr. Joyce Regi M.D (Path),D.P.B. Holy Family Hospital & Research Centre

Dr. Joyce Regi M.D (Path),D.P.B. Holy Family Hospital & Research Centre Dr. Joyce Regi M.D (Path),D.P.B. Holy Family Hospital & Research Centre Autoimmune haemolytic anaemia is charaterised by shortened red cell survival & the presence of antibodies directed against autologous

More information

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital

Bor-Sheng Ko. Hematology Division, Department of Internal Medicine, National Taiwan University Hospital Bor-Sheng Ko Hematology Division, Department of Internal Medicine, National Taiwan University Hospital On behalf of Members of Aplastic Anemia Consensus Meeting Diagnosis and classification: Treatment

More information

Types of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014

Types of Anaemias and their Management. S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014 Types of Anaemias and their Management S. Moncrieffe, Pharm.D., MPH, Dip.Ed., RPh. PSJ CE Mandeville Hotel April 27, 2014 Objectives At the end of the presentations participants should be able to: 1. Define

More information

Bone Marrow Transplantation

Bone Marrow Transplantation Bone Marrow Transplantation Introduction Bone marrow is the spongy tissue inside all of your bones, including your hip and thigh bones. The bone marrow is like a factory that makes different types of blood

More information

2. Non- hemolytic anemias 3. Normocytic Normochromic Normocytic Normochromic Blood loss. (MCV<80 fl) (MCV fl) (MCV>100 fl)

2. Non- hemolytic anemias 3. Normocytic Normochromic Normocytic Normochromic Blood loss. (MCV<80 fl) (MCV fl) (MCV>100 fl) Definition of Anaemia of Anaemias Approach for diagnosis of Red cell disorders any condition resulting from a significant decrease in the total body erythrocyte mass due to decrease of Hb and or RBCs Hemoglobin

More information

Does Morphology Matter in 2017

Does Morphology Matter in 2017 Does Morphology Matter in 2017 ISLH May 2017 Kathryn Foucar Distinguished Professor Emerita kfoucar@salud.unm.edu Objectives Recognize unique RBC and WBC abnormalities in non-neoplastic disorders Learn

More information

AN INTERESTING CASE OF ANEMIA WITH AN UNEXPECTED TWIST. Dr SUDHEER

AN INTERESTING CASE OF ANEMIA WITH AN UNEXPECTED TWIST. Dr SUDHEER AN INTERESTING CASE OF ANEMIA WITH AN UNEXPECTED TWIST Dr SUDHEER A 53 yrs old female PRESENTED WITH - Sudden onset of Loss of consciousness at 10 pm in night : - lasting for 5 minutes - sustained head

More information

Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor

Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor Anemia 1: Fourth year Medical Students/ October/21/ 2015/ Abdallah Abbadi.MD.FRCP Professor Email: abdalla.awidi@gmail.com Main Hematological diseases A- Benign Hematology 1- Anemias 2- Bleeding disorders

More information

Paroxysmal Nocturnal Hemoglobinuria

Paroxysmal Nocturnal Hemoglobinuria Paroxysmal Nocturnal Hemoglobinuria Current Thinking On the Disease Diagnosis and Treatment Ilene Ceil Weitz, MD Associate Clinical Professor of Medicine Jane Anne Nohl Division of Hematology Keck-USC

More information

FBC interpretation. Dr. Gergely Varga

FBC interpretation. Dr. Gergely Varga FBC interpretation Dr. Gergely Varga #1 71 Y/O female, c/o weakness Test Undertaken : FBC (FBC) Sample Type: Whole Blood [ - 26.09.11 14:59] Hb 7.3 g/dl* 12.0-15.5 RBC 3.5 10^12/l * 3.80-5.60 Hct 0.24

More information

PNH: Current Thinking on the Disease, Diagnosis and Treatment. What is PNH? 7/6/2009. Paroxysmal sudden onset Nocturnal

PNH: Current Thinking on the Disease, Diagnosis and Treatment. What is PNH? 7/6/2009. Paroxysmal sudden onset Nocturnal PNH: Current hinking on the Disease, Diagnosis and reatment Jaroslaw Maciejewski, MD, PhD Cleveland Clinic Carlos M. de Castro, MD Duke University Medical Center Paroxysmal sudden onset Nocturnal occuring

More information

Laboratory Techniques. Tehran Medical Branch Islamic Azad University

Laboratory Techniques. Tehran Medical Branch Islamic Azad University Anemia Laboratory Techniques Behzad Poopak, DCLS PhD Tehran Medical Branch Islamic Azad University bpoopak@yahoo.com Learning Objectives Review the anemia as a public health problem Review the lab tests

More information

Apellis Company Presentation March 2019

Apellis Company Presentation March 2019 Apellis Company Presentation March 219 Forward looking statements Statements in this presentation about future expectations, plans and prospects, as well as any other statements regarding matters that

More information

Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort

Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean PNH cohort BLOOD RESEARCH VOLUME 52 ㆍ NUMBER 3 September 2017 ORIGINAL ARTICLE Efficacy of eculizumab in paroxysmal nocturnal hemoglobinuria patients with or without aplastic anemia: prospective study of a Korean

More information

Introduction and Approach to Anemia

Introduction and Approach to Anemia 2 nd lecture in Hematology by Dr.Alaa Fadhil Alwan Introduction and Approach to Anemia Anemia is defined clinically as a blood hemoglobin or hematocrit value that is below the appropriate reference range

More information

Case Presentation No. 075

Case Presentation No. 075 Case Presentation No. 075 Session 4. Myelodysplastic Syndrome Cristina Montalvo, MD Baylor College of Medicine Houston, Texas 2007 Workshop of Society for Hematopathology and European Association for Haematopathology

More information

Susan Stegman, MD Medical Director AXA Equitable Life May 3, 2016

Susan Stegman, MD Medical Director AXA Equitable Life May 3, 2016 Susan Stegman, MD Medical Director AXA Equitable Life May 3, 2016 Underwriting impact Anemia overview Classification of anemia Specific anemia topics Iron deficiency anemia Thalassemia Megaloblastic anemia

More information

رناد زكريا Dr. ahmad Dr. ahmad. P a g e 1

رناد زكريا Dr. ahmad Dr. ahmad. P a g e 1 5 رناد زكريا Dr. ahmad Dr. ahmad P a g e 1 Before we start. -This sheet was written according to section 2 s record and reviewed according to section 1 s record by Ruba Hussien with all thanks and I referred

More information

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY

HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEAMATOLOGICAL INDICES AND BONE MARROW BIOPSY HEMATOCRIT Hematocrit is a measure of the percentage of the total blood volume that is made up by the red blood cells The hematocrit can be determined directly

More information

Anemia In the Insurance Applicant What do the numbers mean?

Anemia In the Insurance Applicant What do the numbers mean? Anemia In the Insurance Applicant What do the numbers mean? Lisa Duckett, M.D. Vice President and Medical Director September 12, 2017 Goals of the presentation Develop a consistent way to analyze Complete

More information

eculizumab, 300mg concentrate for solution for infusion (Soliris ) SMC No. (436/07) Alexion Pharma UK Ltd

eculizumab, 300mg concentrate for solution for infusion (Soliris ) SMC No. (436/07) Alexion Pharma UK Ltd eculizumab, 300mg concentrate for solution for infusion (Soliris ) SMC No. (436/07) Alexion Pharma UK Ltd 8 October 2010 (Amended 11 July 2011) The Scottish Medicines Consortium (SMC) has completed its

More information

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY

YEREVAN STATE MEDICAL UNIVERSITY DEPARTMENT OF HEMATOLOGY COURSE DESCRIPTION HEMATOLOGY 1. Module/unit Code II. 1.2. 2. Module/unit Title Hematology 3. Subject Field Internal Diseases Group 4. Faculty/Department General Medicine, Department of Hematology 5. Programme(s) to which the Doctor

More information

Dana Alsulaibi. - Ahmad Almuhtaseb. - Tariq Al - Adaily

Dana Alsulaibi. - Ahmad Almuhtaseb. - Tariq Al - Adaily - 2 - Dana Alsulaibi - Ahmad Almuhtaseb - Tariq Al - Adaily This sheet will talk about 4 diseases that cause hemolytic anemia, best of luck! 1) Hereditary Spherocytosis Transferred through inheritance

More information

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss

Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Taking The Fear Out of Abnormal CBC s Problems of Production, Destruction or loss Joanne Eddington, MN, FNP, AOCN Providence Oncology and Hematology Care Clinic - Eastside Blood Cell Abnormalities Abnormalities

More information

Avoiding Early Cancer Claims. Presentation #4. Hank George, FALU

Avoiding Early Cancer Claims. Presentation #4. Hank George, FALU Avoiding Early Cancer Claims Presentation #4 Hank George, FALU Hematology and High Risk of Early Cancer Claims Mild Anemia in elders is underpriced by insurers most likely because of its high prevalence

More information

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital

Rory McCulloch. Specialty Trainee Haematology Royal Devon & Exeter Hospital Rory McCulloch Specialty Trainee Haematology Royal Devon & Exeter Hospital Anaemia 1 Haematological disorders Anaemia 2 Non-haematological disorders Substrates: Iron, folate, vitamin B12 Red cell mass

More information

PNH. What is PNH? 7/12/2016 PNH. What is PNH? 1 st published case report of PNH

PNH. What is PNH? 7/12/2016 PNH. What is PNH? 1 st published case report of PNH AA-MDS Patient Conference Raleigh / Durham July 016 : Current Thinking on the Disease, Diagnosis, and Treatment What is? What causes? What are the clinical symptoms of? How is diagnosed? What are the long-term

More information

namib la UnIVERSITY OF SCIEnCE AnD TECHnOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES

namib la UnIVERSITY OF SCIEnCE AnD TECHnOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES namib la UnIVERSITY OF SCIEnCE AnD TECHnOLOGY FACULTY OF HEALTH AND APPLIED SCIENCES DEPARTMENT OF HEALTH SCIENCES QUALIFICATION: BACHELOR OF BIOMEDICAL SCIENCES QUALIFICATION CODE: SOBBMS LEVEL: 6 COURSE

More information

Soliris Medical Policy Prior Authorization Program Summary

Soliris Medical Policy Prior Authorization Program Summary Soliris Medical Policy Prior Authorization Program Summary Precertification/Prior Authorization may be required under certain plans. Please verify each member s benefits. OBJECTIVE The intent of the Soliris

More information

Case Report Myeloid Neoplasms in the Guise of Nutritional Deficiency

Case Report Myeloid Neoplasms in the Guise of Nutritional Deficiency Hindawi Publishing Corporation Case Reports in Hematology Volume 2012, Article ID 826939, 5 pages doi:10.1155/2012/826939 Case Report Myeloid Neoplasms in the Guise of Nutritional Deficiency Veda Parthasarathy

More information

20/01/1439. Prof. M. Rushdi. Prof. Mahmoud Rushdi Faculty of Veterinary Medicine Assiut University Egypt.

20/01/1439. Prof. M. Rushdi. Prof. Mahmoud Rushdi Faculty of Veterinary Medicine Assiut University Egypt. By Prof. Mahmoud Rushdi Faculty of Veterinary Medicine Assiut University Egypt 1 CBC in Dog 2 1 Evaluation of the red blood cells (RBCs) Erythrocytes picture Determination of RBCs count (/mm 3 or T/l)

More information

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust

Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Abnormal blood counts in children Dr Tina Biss Consultant Paediatric Haematologist Newcastle upon Tyne Hospitals NHS Foundation Trust Regional Paediatric Specialty Trainees teaching 4 th July 2017 Scope

More information

Classification of Anaemia

Classification of Anaemia Classification of Anaemia Dr Roger Pool Department of Haematology NHLS & University of Pretoria MEASUREMENT OF HAEMATOCRIT The haematocrit ratio (Hct) is the proportion of blood made up of cells - mainly

More information

Successful use of eculizumab in an 86-year-old patient with paroxysmal nocturnal hemoglobinuria in Japan

Successful use of eculizumab in an 86-year-old patient with paroxysmal nocturnal hemoglobinuria in Japan Ooe and Nagai SpringerPlus 2014, 3:10 a SpringerOpen Journal CASE STUDY Open Access Successful use of eculizumab in an 86-year-old patient with paroxysmal nocturnal hemoglobinuria in Japan Yokiko Ooe 1*

More information

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C.

Extra Notes 3. Warm. In the core (center) of the body, where the temperature is 37 C. Extra Notes 3 *The numbers of the slides are according to the last year slides. Slide 33 Autoimmune hemolytic anemia : Abnormal circulating antibodies that target normal antigen on the RBC and cause lysis.

More information

JPM Presentation January 9, 2018

JPM Presentation January 9, 2018 JPM Presentation January 9, 18 Forward looking statements Statements in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not

More information

DOUBLE WHAMMY DR K.JAGADEESWAR REDDY DNB MEDICINE

DOUBLE WHAMMY DR K.JAGADEESWAR REDDY DNB MEDICINE DOUBLE WHAMMY DR K.JAGADEESWAR REDDY DNB MEDICINE 52 yrs male who is hailing from Mannargudi of Tamilnadu Chief c/o excessive fatigue, exertional dyspnea, black coloured stools on and off, bleeding from

More information

9/23/2018. Investigation of Hemolysis in the Clinical Laboratory. Objectives. What is hemolysis?

9/23/2018. Investigation of Hemolysis in the Clinical Laboratory. Objectives. What is hemolysis? Investigation of Hemolysis in the Clinical Laboratory Jason Anderson, MPH, MT(ASCP) Field Product Specialist Objectives 1. Define hemolysis. 2. Distinguish between intrinsic and extrinsic hemolysis 3.

More information